Alternative polyadenylation as a novel mediator of therapeutic resistance in lung cancer
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110646
- Recipient
-
Health Research, Inc. UEI YDWAYVVQHNK5 Part of Health Research, Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $168,200
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Originally
- Place of performance
- Buffalo, NY 14263, USA
Award details come from USAspending.gov.
About this award
The Defense Health Agency awarded a $168,200 Project Grant to Health Research, Inc. Roswell Park Division under the Military Medical Research and Development program (CFDA 12.420) to investigate alternative polyadenylation as a mediator of therapeutic resistance in lung cancer. The two-year award beginning July 1, 2021 will support research into innovative medical solutions for lung cancer treatment through the study of alternative polyadenylation, a novel area of investigation that could help overcome resistance to current therapies. As part of the Military Medical Research and Development program's goal of transforming military and public health through impactful biomedical research, this grant seeks to advance understanding and treatment of lung cancer, a significant health issue for both the military and general population.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $168,200 |
Quick answers
Who received award W81XWH2110646?
W81XWH2110646 was awarded to Health Research, Inc. by Defense Health Agency (Department of Defense) on July 1, 2021.
How much is award W81XWH2110646 worth?
$168,200 has been obligated on W81XWH2110646.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award